PAREXELGPT Trademark

Trademark Overview


On Tuesday, August 8, 2023, a trademark application was filed for PAREXELGPT with the United States Patent and Trademark Office. The USPTO has given the PAREXELGPT trademark a serial number of 98122534. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Thursday, May 30, 2024. This trademark is owned by Parexel International (MA) Corporation. The PAREXELGPT trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

market research and business marketing consulting services in pharmaceutical, biotechnology, medical device, and diagnostics industries; market analysis using artificial intelligence; business and statistical information and data processing services in the pharmaceutical, biotechnology, medical device, and diagnostics industries

conducting clinical trials for others; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of chemicals, pharmaceuticals, medical devices and medical diagnostics; consulting services using artificial intelligence in the field of conducting clinical trials, regulatory affairs, and drug development
parexelgpt

General Information


Serial Number98122534
Word MarkPAREXELGPT
Filing DateTuesday, August 8, 2023
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateThursday, May 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Pseudo MarkPAREXEL GPT
Goods and Servicesmarket research and business marketing consulting services in pharmaceutical, biotechnology, medical device, and diagnostics industries; market analysis using artificial intelligence; business and statistical information and data processing services in the pharmaceutical, biotechnology, medical device, and diagnostics industries
Goods and Servicesconducting clinical trials for others; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of chemicals, pharmaceuticals, medical devices and medical diagnostics; consulting services using artificial intelligence in the field of conducting clinical trials, regulatory affairs, and drug development

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 7, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameParexel International (MA) Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Party NameParexel International (MA) Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Trademark Events


Event DateEvent Description
Friday, August 11, 2023NEW APPLICATION ENTERED
Thursday, September 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2024ASSIGNED TO EXAMINER
Wednesday, April 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 30, 2024EXTENSION OF TIME TO OPPOSE RECEIVED